We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News   Oct 14, 2019 | Original story from the University of South Florida Health (USF Health)

 
Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

High-resolution fluorescent confocal images showing human airway smooth cells exposed to three different drugs over 15 hours: The drug diphenhydramine (DPD), bottom row, retains more TAS2R14 bitter taste receptors (red) on the cell surface, undergoing less degradation than the receptors interacting with the drugs chlorhexidine (CLX) and flufenamic (FFA). The more pronounced yellow in middle and upper right frames represents co-localization of the receptor (red) and an endosome marker (green), meaning that the receptors binding to CLX and FFA have already been taken inside the cells and are on a path to being degraded. Credit: Images generated by instrumentation in the Microscopy Core at the University of South Florida Byrd Alzheimer's Center

 
 
 

RELATED ARTICLES

Vaccine Can Reduce Likelihood of Severe Pneumonia by Up to 35%

News

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

READ MORE

Blood Test Could Reveal High Risk Heart Patients in Need of Treatment

News

Without occasionally looking under the hood, it’s difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren’t currently in treatment.

READ MORE

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE